NCT00120861View on ClinicalTrials.gov

Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2005

Conditions

Chronic Hepatitis C

Interventions

DRUG

valopicitabine

DRUG

pegylated interferon

DRUG

ribavirin

Trial Locations (11)

Unknown

Birmingham

Los Angeles

San Francisco

Miami

Baltimore

Boston

Detroit

New York

Dallas

Houston

San Antonio

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00120861 - Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy | Biotech Hunter | Biotech Hunter